// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

The Impact of Reduction of Warm Ischemia on DCD Kidney Transplantation Outcomes

S. Aquil - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

The Implications of Donor Proteinuria in Deceased Donor Kidney Transplantation

A. Vinson - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Albuminuria

N/A

The Molecular Features of Chronic Lung Allograft Dysfunction (CLAD) in Transbronchial and Endobronchial Mucosa Biopsies

M. D. Parkes - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Molecular Pathology of Immune Checkpoint Inhibitor-Associated Renal Allograft Rejection: Overlap with Acute Interstitial Nephritis

B. Adam - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Other

Rapidly progressive glomerulonephritis

N/A

The Polish Troubled Kidney Transplant Biopsy Study: External Validation of the Molecular Microscope System

M. Myślak - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Tolerance to ABO A-Antigen Following Treatment of Infant Mice with A-Expressing MHC-Identical Erythrocytes

B. Motyka - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Total Parenteral Nutrition in Ex Vivo Lung Perfusion: Addressing Metabolism Improves Both Inflammation and Overall Graft Performance

M. T. Buchko - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxyzine

Treg Plasticity is Induced by ENV,HERV1_I and UPR Activation in De Novo Autoimmune Hepatitis

J. Yao - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Autoimmune hepatitis

N/A

Unusual Suspects: Real Time Physiological Evaluation of Stressors during Laparoscopic Donor Nephrectomy

C. A. Wilson - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Use of Opioids and NSAIDs in Living Kidney Donors: Clinical Correlates and Early Outcomes

K. Lentine - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Epimorph

Using Ensembles of Machine Learning Classifiers to Maximize the Accuracy and Stability of Molecular Biopsy Interpretation

J. Reeve - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Chronic antibody mediated rejection

N/A

Validation Of The Optimized Prediction Of Mortality (Opom) Machine Learning Model For Non-hepatocellular Carcinoma Candidates Awaiting Liver Transplant

L. Lau - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Induced Pulmonary Inflammation

T. Vassilakopoulos - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Comparison of Normal Lung Anatomy to Minimal to Established Fibrosis in Idiopathic Pulmonary Fibrosis

F. Xu - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Palliative Care Use Around the Time of Chronic Obstructive Lung Disease Hospitalization Among Persons with Chronic Obstructive Lung Disease in Ontario, Canada

L. C. Maclagan - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic obstructive pulmonary disease

N/A

Perspectives on Advance Care Planning for Patients with Hematologic Malignancy

J. Spring - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Hematological malignancies

N/A

Predicting Safe Liberation from Venovenous Extracorporeal Membrane Oxygenation in Patients with Severe Acute Respiratory Distress Syndrome

A. A. Al-Fares - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Acute lung injury

N/A

Propagation of Lung Injury in a Large Animal Model of Acid Aspiration

Y. Xin - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Visualizing Regional Changes Between Lateral, Supine and Prone Position in Pigs with Lung Injury

Y. Xin - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Depleted Diesel Exhaust with Allergen Exposure on DNA Methylation: Bronchial Brushing and Peripheral Blood Mononuclear Cell (PBMC) Results from a Controlled Human Crossover Study

C. F. Rider - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved